Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directionsRiccardo Gerosa, Alberto Zambelli, Rita De Sanctis et al.|Critical Reviews in Oncology/Hematology|2024Cited by 87
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC)Stefano Cavalieri, Lisa Licitra, Michele Del Vecchio et al.|Future Oncology|2023Cited by 20
T-Cell Activation and Maturation at Tumor Site Associated With Objective Response to Ipilimumab in Metastatic MelanomaMichele Del Vecchio, Andrea Anichini, Roberta Mortarini et al.|Journal of Clinical Oncology|2011Cited by 8
Recurrent respiratory papillomatosis: role of bevacizumab and HPV vaccination. A literature review with case presentationsSilvio Sporeni, Giulia Bertino, Francesca Rifaldi et al.|Radiology and Oncology|2025Cited by 2
Resilience in Cancer Care at the Time of COVID-19: Practical Approach to the Management of Cancer Patients During the COVID-19 Emergency in a Large Italian Community HospitalAngioletta Lasagna, Paolo Pedrazzoli, Simona Secondino et al.|Unknown|2020Cited by 1